Details

NameSymbolSector
BROOKS LABORATORIES LIMITEDBROOKSPharmaceuticals
Open
164
High
164.02
Low
150.15
Close
150.73
Volume
43041
Exchange
nse
Time
14/08

Outlook

Score:  

1.75

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Brooks Laboratories is  
Marubozu
Estimated Stoploss of Brooks Laboratories is ₹  
164.02
Brooks Laboratories has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Brooks Laboratories has chances of  
Continuationℹ
 of the current trend. 

Trend

Brooks Laboratories is in  
Sideways trendℹ
. 
Price of Brooks Laboratories is  
Upℹ
 by  

0.94

%. 
Target
Buy @ 

122.91

Sell @ 

166.31

Volume

The trades of Brooks Laboratories have been in  
Immenseℹ
 volume. 
The volume trades for Brooks Laboratories are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Brooks Laboratories is  

Up

 by  

96.57

% 

Valuation

The current market price of Brooks Laboratories is  
Overvaluedℹ

Financials

Balance
The balance sheet of Brooks Laboratories is:  

Balanced

Cashflow
Brooks Laboratories has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

2.22% i.e. ₹ 2cr earned in operatingℹ
50% i.e. ₹ 45cr spent in investingℹ
47.78% i.e. ₹ 43cr earned in financingℹ
0% in otherℹ
Brooks Laboratories has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

50% i.e. ₹ 9cr spent in operatingℹ
0% in investingℹ
50% i.e. ₹ 9cr earned in financingℹ
0% in otherℹ
Income
The income of Brooks Laboratories is  

₹ 25cr

 and  

Profit

 is :  

₹ 2cr

(*Jun 2025)

Brooks Laboratories Profit is up by:  

100

% and Income is Up by:  

8.7

% 

(*Jun 2025)

The income of Brooks Laboratories is  

₹ 23cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Brooks Laboratories Profit is up by:  

100

% and Income is Down by:  

39.47

% 

(*Mar 2025)

The income of Brooks Laboratories is  

₹ 38cr

 and  

Loss

 is :  

₹ 0cr

(*Dec 2024)

Brooks Laboratories Losses increased by:  

0

% and Income is Up by:  

90

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.